{"id":"https://openalex.org/W1983523716","doi":"https://doi.org/10.1016/s0014-2999(96)00500-6","title":"Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells","display_name":"Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells","publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W1983523716","doi":"https://doi.org/10.1016/s0014-2999(96)00500-6","mag":"1983523716","pmid":"https://pubmed.ncbi.nlm.nih.gov/8957230"},"language":"en","primary_location":{"id":"doi:10.1016/s0014-2999(96)00500-6","doi":"https://doi.org/10.1016/s0014-2999(96)00500-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-2999(96)00500-6","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://my-pharm.repo.nii.ac.jp/record/2002139/files/Meiyakukiyou_027_39.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110476924","display_name":"Kanako Ito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114911","display_name":"Meiji (Japan)","ror":"https://ror.org/027tjex48","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210114911"]},{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kanako Ito","raw_affiliation_strings":["Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan","Department of Pharmacology, Meiji College of Pharmacy, 1\u201335-23 Nozawa, Setagaya, Tokyo 154, Japan","Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, Tokyo, Japan","institution_ids":["https://openalex.org/I4210151964"]},{"raw_affiliation_string":"Department of Pharmacology, Meiji College of Pharmacy, 1\u201335-23 Nozawa, Setagaya, Tokyo 154, Japan","institution_ids":["https://openalex.org/I4210114911"]},{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111637935","display_name":"Ken Nakazawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Ken Nakazawa","raw_affiliation_strings":["Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052217673","display_name":"Schuichi Koizumi","orcid":"https://orcid.org/0000-0001-6184-3106","observed_orcids":["https://orcid.org/0000-0001-6184-3106"]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Schuichi Koizumi","raw_affiliation_strings":["Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100674204","display_name":"Min Liu","orcid":"https://orcid.org/0000-0002-6385-8077","observed_orcids":["https://orcid.org/0000-0002-6385-8077","https://orcid.org/0009-0004-6297-5855"]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Min Liu","raw_affiliation_strings":["Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108534716","display_name":"Kouichi Takeuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114911","display_name":"Meiji (Japan)","ror":"https://ror.org/027tjex48","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210114911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kouichi Takeuchi","raw_affiliation_strings":["Department of Pharmacology, Meiji College of Pharmacy, 1\u201335-23 Nozawa, Setagaya, Tokyo 154, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Meiji College of Pharmacy, 1\u201335-23 Nozawa, Setagaya, Tokyo 154, Japan","institution_ids":["https://openalex.org/I4210114911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014311489","display_name":"Takao Hashimoto","orcid":"https://orcid.org/0000-0003-2814-4869","observed_orcids":["https://orcid.org/0000-0003-2814-4869"]},"institutions":[{"id":"https://openalex.org/I4210114911","display_name":"Meiji (Japan)","ror":"https://ror.org/027tjex48","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210114911"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takao Hashimoto","raw_affiliation_strings":["Department of Pharmacology, Meiji College of Pharmacy, 1\u201335-23 Nozawa, Setagaya, Tokyo 154, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Meiji College of Pharmacy, 1\u201335-23 Nozawa, Setagaya, Tokyo 154, Japan","institution_ids":["https://openalex.org/I4210114911"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108379659","display_name":"Yasuo Ohno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuo Ohno","raw_affiliation_strings":["Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan","institution_ids":["https://openalex.org/I4210151964"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101984820","display_name":"Kazuhide Inoue","orcid":"https://orcid.org/0000-0003-0385-9577","observed_orcids":["https://orcid.org/0000-0003-0385-9577"]},"institutions":[{"id":"https://openalex.org/I4210151964","display_name":"National Institute of Health Sciences","ror":"https://ror.org/04s629c33","country_code":"JP","type":"facility","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210151964"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhide Inoue","raw_affiliation_strings":["Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacology, National Institute of Health Sciences, 1\u201318-1 Kamiyoga, Setagaya, Tokyo 158, Japan","institution_ids":["https://openalex.org/I4210151964"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111637935"],"corresponding_institution_ids":["https://openalex.org/I4210151964"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":0.8322,"has_fulltext":true,"cited_by_count":39,"citation_normalized_percentile":{"value":0.69563087,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"314","issue":"1-2","first_page":"143","last_page":"150"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.9442999958992004,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.030400000512599945,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9649999737739563},{"id":"https://openalex.org/keywords/l-type-calcium-channels","display_name":"L-type calcium channels","score":0.8759999871253967},{"id":"https://openalex.org/keywords/voltage-gated-calcium-channels","display_name":"voltage-gated calcium channels","score":0.7789999842643738},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.8880000114440918},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9290000200271606},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.984000027179718},{"id":"https://openalex.org/keywords/fluspirilene","display_name":"fluspirilene","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pimozide","display_name":"pimozide","score":1.0},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":0.9380000233650208},{"id":"https://openalex.org/keywords/sch-23390","display_name":"SCH 23390","score":0.953000009059906},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dopamine-d1-receptor-antagonist","display_name":"dopamine D1 receptor antagonist","score":0.9890000224113464},{"id":"https://openalex.org/keywords/calmodulin-antagonists","display_name":"calmodulin antagonists","score":0.9950000047683716},{"id":"https://openalex.org/keywords/calmidazolium","display_name":"calmidazolium","score":0.8679999709129333},{"id":"https://openalex.org/keywords/w-7","display_name":"W-7","score":0.9210000038146973},{"id":"https://openalex.org/keywords/barium-currents","display_name":"barium currents","score":0.7870000004768372},{"id":"https://openalex.org/keywords/potassium-channel-inhibition","display_name":"potassium channel inhibition","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6788415312767029},{"id":"https://openalex.org/C148043351","wikidata":"https://www.wikidata.org/wiki/Q4456944","display_name":"Current (fluid)","level":2,"score":0.5238609313964844},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5148996114730835},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40187370777130127},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.39836713671684265},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2741067409515381},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26593220233917236},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1526050567626953},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1429993212223053},{"id":"https://openalex.org/C127313418","wikidata":"https://www.wikidata.org/wiki/Q1069","display_name":"Geology","level":0,"score":0.10154217481613159},{"id":"https://openalex.org/C111368507","wikidata":"https://www.wikidata.org/wiki/Q43518","display_name":"Oceanography","level":1,"score":0.05523863434791565}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002147","descriptor_name":"Calmodulin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004558","descriptor_name":"Electric Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010673","descriptor_name":"Pheochromocytoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015220","descriptor_name":"Calcium Channels","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015640","descriptor_name":"Ion Channel Gating","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016716","descriptor_name":"PC12 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0014-2999(96)00500-6","doi":"https://doi.org/10.1016/s0014-2999(96)00500-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0014-2999(96)00500-6","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8957230","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8957230","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:07553:0007446027","doi":null,"is_oa":true,"landing_page_url":"https://my-pharm.repo.nii.ac.jp/records/2002139","pdf_url":"https://my-pharm.repo.nii.ac.jp/record/2002139/files/Meiyakukiyou_027_39.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"THE BULLETIN OF MEIJI PHARMACEUTICAL UNIVERSITY","raw_type":"other"}],"best_oa_location":{"id":"pmh:oai:irdb.nii.ac.jp:07553:0007446027","doi":null,"is_oa":true,"landing_page_url":"https://my-pharm.repo.nii.ac.jp/records/2002139","pdf_url":"https://my-pharm.repo.nii.ac.jp/record/2002139/files/Meiyakukiyou_027_39.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"THE BULLETIN OF MEIJI PHARMACEUTICAL UNIVERSITY","raw_type":"other"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1983523716.pdf","grobid_xml":"https://content.openalex.org/works/W1983523716.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1511964476","https://openalex.org/W1639466988","https://openalex.org/W1881545693","https://openalex.org/W1883270044","https://openalex.org/W1970814820","https://openalex.org/W1971702542","https://openalex.org/W1978322781","https://openalex.org/W1980329167","https://openalex.org/W1989977352","https://openalex.org/W1991916070","https://openalex.org/W1998250660","https://openalex.org/W2008640420","https://openalex.org/W2009667219","https://openalex.org/W2018761524","https://openalex.org/W2019027725","https://openalex.org/W2030740718","https://openalex.org/W2035946947","https://openalex.org/W2063701488","https://openalex.org/W2085698763","https://openalex.org/W2118309627","https://openalex.org/W2145586786","https://openalex.org/W2180452219","https://openalex.org/W2253302896","https://openalex.org/W2268120706","https://openalex.org/W2294946349","https://openalex.org/W2406722107","https://openalex.org/W2410835544","https://openalex.org/W6639423400"],"related_works":["https://openalex.org/W4403943617","https://openalex.org/W1980329167","https://openalex.org/W2258944046","https://openalex.org/W2019027725","https://openalex.org/W1511964476","https://openalex.org/W2008640420","https://openalex.org/W1881545693","https://openalex.org/W1915269017","https://openalex.org/W2074619602","https://openalex.org/W192207125"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}